Skip to main content
TipRanks
Go Ultimate75% OFF

Cyfuse Biomedical K.K. (4892) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Cyfuse Biomedical K.K. has a market cap or net worth of JPY 5.19B. The enterprise value is JPY 3.38B.

Market Cap
JPY 5.19B
Enterprise Value
JPY 3.38B

Share Statistics

Cyfuse Biomedical K.K. has 10,092,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
10,092,100
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Cyfuse Biomedical K.K.’s return on equity (ROE) is -0.28 and return on invested capital (ROIC) is -20.35%.

Return on Equity (ROE)
-0.28
Return on Assets (ROA)
-0.18
Return on Invested Capital (ROIC)
-20.35%
Return on Capital Employed (ROCE)
-0.24
Revenue Per Employee
10.04M
Profits Per Employee
-33.21M
Employee Count
23
Asset Turnover
0.05
Inventory Turnover
1.72

Valuation Ratios

The current PE Ratio of Cyfuse Biomedical K.K. is -6.28. Cyfuse Biomedical K.K.’s PEG ratio is -0.30.

PE Ratio
-6.28
PS Ratio
16.86
PB Ratio
1.96
Price to FCF
0.00
Price to Operating Cash Flow
0.00
PEG Ratio
-0.30

Income Statement

In the last 12 months, Cyfuse Biomedical K.K. had revenue of 231.00M and earned -763.84M in profits. Earnings per share was -86.78.

Revenue
231.00M
Gross Profit
78.40M
Operating Income
-828.18M
Pretax Income
-761.30M
Net Income
-763.84M
EBITDA
-792.68M
Earnings Per Share (EPS)
-86.78

Cash Flow

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow
0
Free Cash Flow
0
Free Cash Flow per Share
0.00

Dividends & Yields

Cyfuse Biomedical K.K. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
0.00%
Earnings Yield
-15.38%

Stock Price Statistics

Beta
0.46
52-Week Price Change
-12.29%
50-Day Moving Average
609.04
200-Day Moving Average
599.60
Relative Strength Index (RSI)
34.89
Average Volume (3m)
50.01K

Important Dates

Cyfuse Biomedical K.K. upcoming earnings date is Feb 12, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 13, 2026
Next Earnings Date
Feb 12, 2027
Ex-Dividend Date
―

Financial Position

Cyfuse Biomedical K.K. as a current ratio of 4.54, with Debt / Equity ratio of 47.58%

Current Ratio
4.54
Quick Ratio
4.44
Debt to Market Cap
0.25
Net Debt to EBITDA
3.05
Interest Coverage Ratio
-58.00

Taxes

In the past 12 months, Cyfuse Biomedical K.K. has paid 2.54M in taxes.

Income Tax
2.54M
Effective Tax Rate
-0.00

Enterprise Valuation

Cyfuse Biomedical K.K. EV to EBITDA ratio is -6.16, with an EV/FCF ratio of 0.00.

EV to Sales
14.97
EV to EBITDA
-6.16
EV to Free Cash Flow
0.00
EV to Operating Cash Flow
0.00

Balance Sheet

Cyfuse Biomedical K.K. has JPY 3.39B in cash and marketable securities with JPY 1.23B in debt, giving a net cash position of JPY 2.16B billion.

Cash & Marketable Securities
JPY 3.39B
Total Debt
JPY 1.23B
Net Cash
JPY 2.16B
Net Cash Per Share
JPY 213.88
Tangible Book Value Per Share
JPY 260.21

Margins

Gross margin is 47.49%, with operating margin of -253.17%, and net profit margin of -260.19%.

Gross Margin
47.49%
Operating Margin
-253.17%
Pretax Margin
-259.36%
Net Profit Margin
-260.19%
EBITDA Margin
-243.01%
EBIT Margin
-253.17%

Analyst Forecast

The average price target for Cyfuse Biomedical K.K. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
364.72%
EPS Growth Forecast
18.43%

Scores

Smart Score
―
AI Score
42